| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.004 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |